ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
78.36
-0.18
(-0.23%)
Closed July 23 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
78.36
Bid
78.12
Ask
79.00
Volume
630,830
78.00 Day's Range 79.20
48.87 52 Week Range 82.76
Market Cap
Previous Close
78.54
Open
78.84
Last Trade
2289
@
78.36
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,033,319
Shares Outstanding
512,302,503
Dividend Yield
2.68%
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Cie de SaintGobain

Sector
Construction Machinery & Eq
Industry
Flat Glass
Headquarters
Courbevoie, Hauts-de-seine, Fra
Founded
1665
Cie de SaintGobain is listed in the Construction Machinery & Eq sector of the Euronext with ticker SGO. The last closing price for Cie de SaintGobain was 78.54 €. Over the last year, Cie de SaintGobain shares have traded in a share price range of 48.87 € to 82.76 €.

Cie de SaintGobain currently has 512,302,503 shares outstanding. The market capitalization of Cie de SaintGobain is 40.24 € billion.

SGO Latest News

Saint-Gobain Acquires Two Flooring Companies

By Pierre Bertrand Compagnie de Saint-Gobain said that it has acquired two companies active in the non-residential flooring market. The French building-materials company said it acquired French...

Saint-Gobain to Sell Majority of UK Foam Insulation Business to Soprema

By David Sachs Saint-Gobain said it would sell a majority stake in its U.K. foam insulation business to Soprema as part of its disposal plan. The French construction supplier said late Wednesday...

Saint-Gobain CEO to Take on Chairman Role

By Adria Calatayud Compagnie de Saint-Gobain Chief Executive Benoit Bazin will add the chairman role when Pierre-Andre de Chalendar retires, completing a corporate-governance reorganization that...

Saint-Gobain Targets Record Operating Margin For 2023 Despite Fall in 3Q Revenue

By Pierre Bertrand Compagnie de Saint-Gobain said it aims to achieve a new record operating margin this year, despite reporting a decline in third-quarter sales. The French building-materials...

Saint-Gobain Agrees to Acquire Concrete-Reinforcement Specialist Adfil

By Pierre Bertrand Compagnie de Saint-Gobain said on Tuesday that it has entered into a definitive agreement to acquire Adfil NV, a company specializing in fibers for concrete reinforcement. Adfil...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.30.38431975403578.0679.6876.8481623078.4166662DE
45.27.1077091306773.1679.6872.4482997976.44231567DE
123.444.5915643352974.9282.7671.62103331977.48360575DE
2614.2322.189302978364.1382.7661.73100284673.43838121DE
5220.4135.220017256357.9582.7648.87104804165.59843854DE
15620.1634.639175257758.282.7635.18115436156.47571692DE
26044.09128.65480011734.2782.7616.408133883746.72590923DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DCAPUnity Wealth Partners Dynamic Capital Appreciation & Options ETF
 20.10
(839.25%)
128.82k
RGCRegencell Bioscience Holdings Ltd
$ 15.15
(349.55%)
1.34M
ATPCAgape ATP Corporation
$ 0.2262
(58.18%)
107.31M
SLRXSalarius Pharmaceuticals Inc
$ 2.34
(51.95%)
60.04M
GSUNGolden Sun Health Technology Group Ltd
$ 7.46
(45.42%)
589.98k
FLYEFly E Group Inc
$ 1.1601
(-81.82%)
25.44M
RNAZTransCode Therapeutics Inc
$ 0.3035
(-61.70%)
9.78M
JAGXJaguar Health Inc
$ 1.755
(-58.90%)
15.47M
MIRAMIRA Pharmaceuticals Inc
$ 2.55
(-49.10%)
25.64M
IVPInspire Veterinary Partners Inc
$ 5.19
(-43.83%)
1.67M
SLNASelina Hospitality PLC
$ 0.026
(-29.73%)
220.18M
SPWRSunPower Corporation
$ 0.9514
(32.91%)
186.75M
NVDANVIDIA Corporation
$ 122.59
(-0.77%)
173.87M
ADILAdial Pharmaceuticals Inc
$ 1.3422
(26.62%)
160.04M
HOLOMicroCloud Hologram Inc
$ 0.588
(26.07%)
135.53M

Discussion

View Full Feed
SSKILLZ1 SSKILLZ1 3 minutes ago
that is tonkin I come to know and love. he stinks. On a positive note mcneil has started to figure out how to hit again.
dmb2 dmb2 3 minutes ago
Gary, I agree that more intelligent latitude can be applied to the approval process knowing patient safety is the primary goal. If a drug is the best available treatment in a life threatening disease and has a benign safety profile, it is logical and humane to do better at making it available. Today
NWBO
Walter4 Walter4 4 minutes ago
https://youtu.be/W0wU3Zb3S50?si=UThyqp0iBG8PfuPb
SONG
zab zab 4 minutes ago
You are not in control of this forum, you can post, but that's it.
fuagf fuagf 5 minutes ago
LOL Broccoli is great, just on a plate, not in a cake.
oystersnbeer oystersnbeer 5 minutes ago
Say it ,
KA-MA-LA,
KA-MA-LA..... PRES-I-DENT!!

https://x.com/ananavarro/status/1815791797085557055
gorbec1 gorbec1 5 minutes ago
Maybe we switching to new company
MCIC
cadillacdave cadillacdave 5 minutes ago
Sorry but "low risk, no reward" equates with a waste of time, worthless venture etc. No one is mischaracterizing what you said - I put it in quotes.

Try to explain it away, but you are getting deeper into the quicksand. Those were your words and that is the plain meaning of it.
WDDD
m$teamworkotc m$teamworkotc 6 minutes ago
californification.hang 10 baby........LFG Jim....copper-silver...m team needs a new Z06
VXIT
dukeb dukeb 6 minutes ago
This company should have been shut down 10 years ago. They had no viable product. The revenue the company brought in was dwarfed by the 6 figure salaries of the 3 top executives and that situation only got worse as the years went by.

There were red flags a plenty and anyone with com
ZRFY
OMOLIVES OMOLIVES 6 minutes ago
Skenes pitching into the 9th. Tied game.
mc73 mc73 6 minutes ago
If one were to assume anything...it would be to assume this company is going bye-bye. Well, at least that is what I assume. I will keep my eye out and jump back in if things look promising.
RSPI
Anshu2 Anshu2 6 minutes ago
That’s a junk/nothing report. More importantly, he hasn’t changed his stance or given justification for his continued belief in the company — after multiple trial failures since the 2022 report.

I sure hope that the current rise in the stock has very little to do with Kolbert’s cover
AVXL
JustMe JustMe 7 minutes ago
Nope! I bought some AMC and GME to keep me occupied.

GO RNVA!!!
AMC GME RNVA
Barron4664 Barron4664 7 minutes ago
Thanks Rodney. My analysis stands. The 10% coupon was offered to Treasury, not agreed to in the SPSPA. Every one of the conditions in that fact sheet was agreed to and was signed by the Director of FHFA and the Secretary of Treasury with the exception of the coupon rate of 10% and or 12% in kind. No
FNMA
TheKid5 TheKid5 8 minutes ago
The growing anticipation is palatable and the masses are getting hugely excited for CLNV!!!🤑
CLNV
BoscoLives21 BoscoLives21 8 minutes ago
Sure jump to a different point! Four Awards at the 2024 NY Int’l Beer Competition, yea or nay?

https://nyibeercompetition.com/winners/2024-winners/

$KEGS
KEGS
Diamondhands45 Diamondhands45 8 minutes ago
Shouldn’t be long then fir the Q
KATX
JH Mcdough JH Mcdough 8 minutes ago
We’re do you stand on this now ? Still think it’s gonna be a runner or did the ball get dropped on us ?
PPJE
SSKILLZ1 SSKILLZ1 8 minutes ago
You see now you tag hopefully mcniel watched that. Vientos couldn't of hit that ball much harder.
JH Mcdough JH Mcdough 9 minutes ago
Is there any chance this recovers or is it dead now ?
PPJE
LCP77 LCP77 9 minutes ago
Okay dude. They can use that! Just post bids enough to pull it off. You’ll be giving wallstreet a riskless 10% return. Got an extra $10,000,000 to make stuff happen?
NB
JH Mcdough JH Mcdough 9 minutes ago
I’ll start out by saying I like CNNA first and for most but how is it going to trade when it’s out of EM and the MMs get their hands on it . Also it’s been in EM for over a year now . That is a very long time to be there with out any action .
CNNA
Alley-oop Alley-oop 10 minutes ago
Huge run is on the way. Buckle up tight!
SMCE